TY - JOUR
T1 - Derivation and validation of the J-CTO extension score for pre-procedural prediction of major adverse cardiac and cerebrovascular events in patients with chronic total occlusions
AU - Ebisawa, Soichiro
AU - Kohsaka, Shun
AU - Muramatsu, Toshiya
AU - Kashima, Yoshifumi
AU - Okamura, Atsunori
AU - Yamane, Masahisa
AU - Sakurada, Masami
AU - Matsuno, Shunsuke
AU - Kijima, Mikihiro
AU - Habara, Maoto
N1 - Funding Information:
Soichiro Ebisawa belongs to Endowed Department of Cardiovascular Medicine of Shinshu University supported by Medtronic Japan Co.,Ltd. Abbott Vascular Japan Co.,Ltd. Boston Scientific Japan, TERUMO CORPORATION, Cardinal Health Japan and NIPRO CORPORATION. The funders provided support in the form of salaries for Soichiro Ebisawa, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. We are grateful to the members of the cardiac catheterization laboratories of the participating centers and the clinical research coordinators.
Publisher Copyright:
Copyright: © 2020 Ebisawa et al.
PY - 2020/9
Y1 - 2020/9
N2 - We developed a prediction model of long-term risk after percutaneous coronary intervention (PCI) for coronary chronic total occlusion (CTO) based on pre-procedural clinical information. A total of 4,139 eligible patients, who underwent CTO-PCI at 52 Japanese centers were included. Specifically, 1,909 patients with 1-year data were randomly divided into the derivation (n = 1,273) and validation (n = 636) groups. Major adverse cardiac and cardiovascular event (MACCE) was the primary endpoint, including death, stroke, revascularization, and non-fatal myocardial infarction. We assessed the performance of our model using the area under the receiver operating characteristic curve (AUC) and assigned a simplified point-scoring system. One-hundred-thirty-eight (10.8%) patients experienced MACCE in the derivation cohort with hemodialysis (HD: odds ratio [OR] = 2.55), left ventricular ejection fractions (LVEF) <35% (OR = 2.23), in-stent occlusions (ISO: OR = 2.27), and diabetes mellitus (DM: OR = 1.72). The AUC of the derivation model was 0.650. The model’s performance was similar in the validation cohort (AUC, 0.610). When assigned a point for each associated factor (HD = 3, LVEF <35%, ISO = 2, and DM = 1 point), the average predicted versus the observed MACCE probability using the Japan-CTO extension score for the low, moderate, high, and very high risk groups was 8.1% vs. 7.3%, 16.9% vs. 15.9%, 22.0% vs. 26.1%, and 56.2% vs. 44.4%, respectively. This novel risk model may allow for the estimation of long-term risk and be useful in disseminating appropriate revascularization procedures.
AB - We developed a prediction model of long-term risk after percutaneous coronary intervention (PCI) for coronary chronic total occlusion (CTO) based on pre-procedural clinical information. A total of 4,139 eligible patients, who underwent CTO-PCI at 52 Japanese centers were included. Specifically, 1,909 patients with 1-year data were randomly divided into the derivation (n = 1,273) and validation (n = 636) groups. Major adverse cardiac and cardiovascular event (MACCE) was the primary endpoint, including death, stroke, revascularization, and non-fatal myocardial infarction. We assessed the performance of our model using the area under the receiver operating characteristic curve (AUC) and assigned a simplified point-scoring system. One-hundred-thirty-eight (10.8%) patients experienced MACCE in the derivation cohort with hemodialysis (HD: odds ratio [OR] = 2.55), left ventricular ejection fractions (LVEF) <35% (OR = 2.23), in-stent occlusions (ISO: OR = 2.27), and diabetes mellitus (DM: OR = 1.72). The AUC of the derivation model was 0.650. The model’s performance was similar in the validation cohort (AUC, 0.610). When assigned a point for each associated factor (HD = 3, LVEF <35%, ISO = 2, and DM = 1 point), the average predicted versus the observed MACCE probability using the Japan-CTO extension score for the low, moderate, high, and very high risk groups was 8.1% vs. 7.3%, 16.9% vs. 15.9%, 22.0% vs. 26.1%, and 56.2% vs. 44.4%, respectively. This novel risk model may allow for the estimation of long-term risk and be useful in disseminating appropriate revascularization procedures.
UR - http://www.scopus.com/inward/record.url?scp=85090883485&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090883485&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0238640
DO - 10.1371/journal.pone.0238640
M3 - Article
C2 - 32915843
AN - SCOPUS:85090883485
SN - 1932-6203
VL - 15
JO - PloS one
JF - PloS one
IS - 9 September
M1 - e0238640
ER -